Cagent Vascular is redefining balloon angioplasty with Serration Remodeling Therapy (SRT). Cagent Vascular is the first and only company to commercialize an angioplasty balloon featuring integrated serrations. Their mission is to elevate vessel preparation and treatment outcomes for patients with Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI).

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
05/21/26	$41,000,000	Series D	Astoria Health Investors US Venture Partners	undisclosed